- Home
- OOMA vs ESPR Comparison
OOMA vs ESPR Comparison
Compare OOMA & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OOMA
- ESPR
- Stock Information
- Founded
- OOMA 2003
- ESPR 2008
- Country
- OOMA United States
- ESPR United States
- Employees
- OOMA N/A
- ESPR N/A
- Industry
- OOMA EDP Services
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- OOMA Technology
- ESPR Health Care
- Exchange
- OOMA Nasdaq
- ESPR Nasdaq
- Market Cap
- OOMA 379.7M
- ESPR 445.6M
- IPO Year
- OOMA 2015
- ESPR 2013
- Fundamental
- Price
- OOMA $12.54
- ESPR $2.84
- Analyst Decision
- OOMA Strong Buy
- ESPR Buy
- Analyst Count
- OOMA 5
- ESPR 6
- Target Price
- OOMA $17.63
- ESPR $6.50
- AVG Volume (30 Days)
- OOMA 186.6K
- ESPR 6.0M
- Earning Date
- OOMA 08-26-2025
- ESPR 11-06-2025
- Dividend Yield
- OOMA N/A
- ESPR N/A
- EPS Growth
- OOMA N/A
- ESPR N/A
- EPS
- OOMA N/A
- ESPR N/A
- Revenue
- OOMA $261,617,000.00
- ESPR $268,125,000.00
- Revenue This Year
- OOMA $6.33
- ESPR $10.59
- Revenue Next Year
- OOMA $6.15
- ESPR N/A
- P/E Ratio
- OOMA N/A
- ESPR N/A
- Revenue Growth
- OOMA 5.42
- ESPR N/A
- 52 Week Low
- OOMA $10.88
- ESPR $0.69
- 52 Week High
- OOMA $17.00
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- OOMA 52.77
- ESPR 79.27
- Support Level
- OOMA $12.43
- ESPR $2.37
- Resistance Level
- OOMA $12.97
- ESPR $2.73
- Average True Range (ATR)
- OOMA 0.42
- ESPR 0.17
- MACD
- OOMA -0.00
- ESPR 0.03
- Stochastic Oscillator
- OOMA 41.64
- ESPR 93.75
About OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service ("SaaS") and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. Ooma generates revenues from the sale of subscriptions and other services.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.